Treace Medical Concepts (TMCI) EBT Margin (2020 - 2026)
Treace Medical Concepts (TMCI) posted EBT Margin of 44.17% for Q1 2026, down 296.68% on a QoQ basis from 11.13% in Q4 2025, and down 1363.0% year-over-year from 3.5% in Q1 2025.
Treace Medical Concepts (TMCI) EBT Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts' EBT Margin history runs 7 years deep, the most recent figure standing at 44.17% for Q1 2026.
- Quarterly EBT Margin fell 1363.0% year-over-year to 44.17% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 29.76% (down 433.0% YoY) and the FY2025 annual result came in at 50.8%, down 547.0% from the prior year.
- EBT Margin was 44.17% for Q1 2026 at Treace Medical Concepts, down from 11.13% in the prior quarter.
- Across five years, EBT Margin topped out at 1.27% in Q4 2024 and bottomed at 120.12% in Q1 2022.
- A 5-year average of 35.65% and a median of 34.11% in 2024 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin jumped 109543 bps — and 2024, when it slumped 1848 bps.
- Treace Medical Concepts' EBT Margin stood at 8.15% in 2022, then dropped by 26 bps to 10.25% in 2023, then jumped by 88 bps to 1.27% in 2024, then plunged by 776 bps to 11.13% in 2025, then tumbled by 297 bps to 44.17% in 2026.
- Business Quant data shows TMCI's EBT Margin at 44.17% in Q1 2026, 11.13% in Q4 2025, and 32.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | -44.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.17% |
| Dec 31, 2025 | -11.13% |
| Sep 30, 2025 | -32.62% |
| Jun 30, 2025 | -36.97% |
| Mar 31, 2025 | -30.53% |
| Dec 31, 2024 | -1.27% |
| Sep 30, 2024 | -34.11% |
| Jun 30, 2024 | -47.95% |
| Mar 31, 2024 | -36.69% |
| Dec 31, 2023 | -10.25% |
| Sep 30, 2023 | -43.04% |
| Jun 30, 2023 | -29.48% |
| Mar 31, 2023 | -32.19% |
| Dec 31, 2022 | -8.15% |
| Sep 30, 2022 | -36.57% |
| Jun 30, 2022 | -50.82% |
| Mar 31, 2022 | -120.12% |
| Dec 31, 2021 | -19.66% |
| Sep 30, 2021 | -922.59% |
| Jun 30, 2021 | -1,146.24% |